Gr-1 is a surface marker on mouse immune cells, detected by the monoclonal antibody clone RB6-8C5, that has been a workhorse of murine immunology for decades. It was originally described as a granulocyte-differentiation antigen found on maturing neutrophils in bone marrow, but the story turned out to be more complicated: the RB6-8C5 antibody actually recognizes two distinct proteins, Ly6G and Ly6C, which sit on overlapping but different cell populations. That dual specificity has been both enormously useful and a persistent source of confusion in the field.
What Gr-1 Actually Recognizes
The Gr-1 antigen was identified as a member of the Ly-6 protein family, a group of small glycosylphosphatidylinositol-anchored proteins ranging from about 21 to 25 kilodaltons in size. The key discovery was that the RB6-8C5 antibody, long used to label granulocytes, reacts with cells expressing either Ly6G or Ly6C when those genes are individually introduced into cell lines that normally carry neither protein.1The Journal of Immunology. Selective expression of Ly-6G on myeloid lineage cells in mouse bone marrow. RB6-8C5 mAb to granulocyte-differentiation antigen (Gr-1) detects members of the Ly-6 family In practice, this means that when you stain mouse cells with an anti-Gr-1 antibody, you are lighting up everything that carries Ly6G, everything that carries Ly6C, and everything that carries both.
The binding is not symmetrical, though. RB6-8C5 attaches with high affinity to Ly6G and with lower affinity to Ly6C. Importantly, the region of the protein that the Gr-1 antibody latches onto overlaps with the spot recognized by the Ly6G-specific antibody clone 1A8, but it does not overlap with the binding site for the Ly6C-specific clone ER-MP20.2PubMed. Gr-1 antibody induces STAT signaling, macrophage marker expression and abrogation of myeloid-derived suppressor cell activity in BM cells This matters because Ly6G and Ly6C are not expressed by the same cell types in the same pattern, and lumping them together under a single “Gr-1” label has caused real interpretive headaches.
Why the Dual Specificity Creates Problems
Neutrophils in the bone marrow and blood express abundant amounts of both Ly6G and Ly6C, so they stain brightly with anti-Gr-1. Monocytes, on the other hand, express Ly6C but not Ly6G. That means monocytes also stain positive for Gr-1, just less intensely than neutrophils do. Researchers who sorted “Gr-1 high” cells often assumed they were getting a pure neutrophil population, when in reality they were pulling out a mix of neutrophils, monocytes, and even some macrophages.3Journal of Leukocyte Biology. Ly6 family proteins in neutrophil biology – Section: Ly6C
A direct comparison using splenic cells made the scale of this problem clear. When researchers sorted “Gr-1 high, intermediate side scatter” cells, the resulting population included neutrophils, monocytes, and macrophages. Switching to separate Ly6G and Ly6C staining resolved the mess: Ly6G-high cells were entirely neutrophils, while Ly6C-positive, Ly6G-negative cells were monocytes and macrophages.4PubMed Central. A novel Ly6C/Ly6G-based strategy to analyze the mouse splenic myeloid compartment For this reason, most immunologists now prefer using anti-Ly6G (clone 1A8) and anti-Ly6C separately rather than relying on Gr-1 alone when they need to distinguish neutrophils from monocytes.
Gr-1 Expression Across Cell Types
Expression of Gr-1 is most prominent on myeloid lineage cells in the bone marrow and rare on lymphocytes, macrophages, or uncommitted precursor cells. Within the myeloid compartment, Gr-1 expression increases as neutrophils mature, making it a rough gauge of differentiation stage. Monocytes show Gr-1 expression too, but it tends to be transient, peaking in bone marrow monocytes and declining as they enter the circulation and tissues.5Journal of Leukocyte Biology. Ly6 family proteins in neutrophil biology – Section: Ly6C
When you unpack that into Ly6C and Ly6G individually, useful distinctions emerge. Circulating monocytes split into at least two functionally different groups based on Ly6C levels. Ly6C-high monocytes are the “inflammatory” subset, rapidly recruited into inflamed tissue during infection or injury. Ly6C-low monocytes patrol the endothelial wall under steady-state conditions, performing a surveillance role that does not depend on acute inflammation.6PubMed. Toll-like receptors elicit different recruitment kinetics of monocytes and neutrophils in mouse acute inflammation None of that resolution is possible if all you have is a single Gr-1 stain.
Ly6C also turns up in places that have nothing to do with the myeloid system. A subset of memory CD8+ T cells expresses Ly6C, and its expression on those cells correlates with increased interferon-gamma production upon restimulation, suggesting it marks T cells that have been through prior antigen encounters.7The Journal of Immunology. Ly-6C is a marker of memory CD8+ T cells This is another reason why interpreting Gr-1 staining as “neutrophils” without further markers can go wrong, particularly in tissues where T cells are abundant.
What Ly6G Actually Does on Neutrophils
For years, Ly6G was treated as little more than a convenient label. It sat on neutrophil surfaces, antibodies could detect it, and that was the end of the story. More recently, though, researchers discovered that engaging Ly6G with an antibody has real functional consequences. Anti-Ly6G blocks neutrophil migration toward chemical attractants, and the mechanism runs through a physical partnership with a class of adhesion molecules called beta-2 integrins. Confocal microscopy and protein-interaction experiments showed that Ly6G and beta-2 integrins sit close together on the neutrophil surface, and binding one disrupts the other.8PubMed Central. Ly6G ligation blocks recruitment of neutrophils via a β2-integrin-dependent mechanism
When the beta-2 integrin gene is knocked out, anti-Ly6G antibody loses its ability to block migration, confirming that the migration effect runs through the integrins rather than some independent pathway. Follow-up work showed this is selective: Ly6G ligation preferentially impairs beta-2 integrin-dependent migration while sparing migration routes that use other adhesion molecules.9Blood Advances. Differential attenuation of β2 integrin–dependent and –independent neutrophil migration by Ly6G ligation The practical implication is that experiments using anti-Ly6G antibody are not just flagging neutrophils passively. They are actively changing how those neutrophils behave, which is something researchers need to account for when interpreting depletion studies.
Depletion Experiments and Their Complications
One of the most common uses of anti-Gr-1 and anti-Ly6G antibodies in research is to deplete neutrophils from living mice in order to ask what happens when neutrophils are absent. Inject the antibody, the antibody-coated cells get cleared by the immune system, and you see what changes. Anti-Ly6G (clone 1A8) became the preferred tool for this because, unlike anti-Gr-1, it does not bind Ly6C and therefore should spare monocytes.10PubMed. Limitations of neutrophil depletion by anti-Ly6G antibodies in two heterogenic immunological models
But depletion is never as clean as it sounds. Removing neutrophils triggers a compensatory response: the body senses the drop in circulating neutrophils and ramps up production of granulocyte colony-stimulating factor (G-CSF), which drives emergency production of new neutrophils in the bone marrow. This feedback loop is density-dependent, meaning the body responds to neutrophil numbers falling below a threshold, and the resulting wave of new neutrophils can look indistinguishable from the kind of granulocyte expansion triggered by infection or inflammatory stimuli.11PubMed Central. Inflammation triggers emergency granulopoiesis through a density-dependent feedback mechanism So a researcher who depletes neutrophils and then sees an inflammatory response has to disentangle whether that response is caused by the missing neutrophils or by the flood of G-CSF and immature granulocytes pouring out of the bone marrow to replace them.
Iron availability adds another layer. One study found that when mice were iron-deficient, the rebound production of neutrophils after anti-Gr-1 depletion was blunted, and providing supplemental iron restored it.12PubMed Central. Plasma iron controls neutrophil production and function This is a good illustration of how variables that seem unrelated to neutrophil biology, such as the mouse’s nutritional status, can quietly reshape the results of a depletion experiment.
Gr-1 in Tumor Immunology
Perhaps the highest-profile use of the Gr-1 marker has been in cancer research, specifically in studying myeloid-derived suppressor cells (MDSCs). Tumors in mice drive the overproduction of immature myeloid cells that express both CD11b and Gr-1 on their surface, and these cells actively suppress the immune system’s ability to attack the tumor.13PubMed Central. Gr-1+CD11b+ myeloid-derived suppressor cells: formidable partners in tumor metastasis Early work described MDSCs as a single CD11b+Gr-1+ population, but the dual specificity problem meant this was a mixed bag from the start.
Sorting MDSCs with Ly6G and Ly6C-specific antibodies split them into two functionally distinct populations. One subset, resembling immature neutrophils, was polymorphonuclear and Ly6G-positive. The other, resembling inflammatory monocytes, was mononuclear and Ly6C-positive but Ly6G-negative. These two subsets suppressed T cells through different molecular mechanisms, meaning their biology was genuinely distinct rather than just a staining artifact.14PubMed. Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cell-suppressive activity This discovery was a turning point. Papers published before this distinction was widely adopted that simply called everything “Gr-1+ MDSCs” are harder to interpret, because you cannot tell which subset was doing the biological heavy lifting.
The role of these cells extends beyond simply dampening the immune response. In mouse mammary tumor models, Gr-1+CD11b+ cells accumulate in the lungs before tumor cells even arrive, creating a “premetastatic niche.” In those lungs, they reduce interferon-gamma production, boost proinflammatory signals, and produce large amounts of matrix metalloproteinase 9, which remodels blood vessels in ways that favor tumor cell colonization. Deleting MMP9 normalized the abnormal vasculature and reduced lung metastasis.15Cancer Research. Gr-1+CD11b+ Myeloid Cells Tip the Balance of Immune Protection to Tumor Promotion in the Premetastatic Lung The picture that emerges is one where tumors hijack immature myeloid cells not only to hide from the immune system but to actively prepare distant organs for metastasis.
Gr-1+ Cells in Infection
Infectious disease models have also relied heavily on Gr-1 staining. In mice infected with highly pathogenic influenza strains, including H5N1 and a reassortant carrying the 1918 pandemic virus hemagglutinin, CD11b+Gr-1+ cells expanded in the blood, lungs, and bone marrow. All infected animals showed increased Gr-1+ cells in blood and lungs, but only animals infected with the highly pathogenic strains showed significant expansion in the bone marrow, suggesting that the scale and location of myeloid cell accumulation tracks with disease severity.16PubMed Central. Accumulation of CD11b+Gr-1+ cells in the lung, blood and bone marrow of mice infected with highly pathogenic H5N1 and H1N1 influenza viruses Beyond merely accumulating, these cells appeared to generate products associated with T-cell suppression within the lung, paralleling the immunosuppressive behavior of MDSCs in tumor settings.
The overlap between infection-induced and tumor-induced myeloid expansion is striking and remains an active research question. In both contexts, the host ramps up production of immature myeloid cells that carry immunosuppressive potential. Whether these are truly the same cells co-opted by different pathological stimuli, or whether infection and tumors each recruit functionally distinct Gr-1+ populations that happen to share surface markers, is still not fully sorted out.
Gr-1+ Cells in Autoimmune Disease
Autoimmune conditions provide another context where Gr-1 staining reveals something biologically interesting. In experimental colitis, a mouse model of inflammatory bowel disease, the granulocytic (Ly6G+) subset of MDSCs expands during active disease. But the inflammatory environment in the colon appears to push these cells into a phenotypic shift: the proportion of Gr-1-high cells decreases while Gr-1-low cells increase, and the cells downregulate a transcription factor critical for their normal suppressive function. In other words, the very inflammation these cells are supposed to dampen seems to rewire them into something less immunosuppressive or possibly even proinflammatory. That kind of context-dependent plasticity makes MDSCs unpredictable therapeutic targets in autoimmune disease, where the goal would be to enhance their suppressive capacity rather than remove it.
Circadian Rhythms Shape Ly6C-High Monocyte Behavior
A finding that caught many immunologists off guard was that inflammatory monocytes, the Ly6C-high subset, do not maintain steady numbers throughout the day. Their abundance in blood and their recruitment to inflamed tissues follow a circadian rhythm controlled by the clock gene Bmal1.17PubMed Central. Circadian gene Bmal1 regulates diurnal oscillations of Ly6C hi inflammatory monocytes This means the time of day a mouse is infected or injured can influence how many inflammatory monocytes show up at the site. For researchers using Gr-1 or Ly6C staining to track monocyte responses, this introduces an experimental variable that many protocols historically did not control for. If you bleed mice at different times and compare Gr-1 staining, you might see differences that have nothing to do with your experimental treatment and everything to do with the clock.
The practical implication extends beyond mouse immunology. If inflammatory monocyte trafficking is genuinely under circadian control, then the timing of therapeutic interventions targeting these cells could matter. Studies in humans have begun to explore parallel ideas, and there is growing recognition that the immune system is not a static entity sampled at convenience but a dynamic one whose composition fluctuates on a 24-hour cycle.
Translating Mouse Gr-1 Findings to Human Immunology
Humans do not express Ly6G. There is no direct human equivalent of the Gr-1 marker, which means findings from mouse studies using Gr-1 staining cannot be translated by simply looking for the same protein on human cells. The monocyte subsets defined by Ly6C in mice do have rough human counterparts defined by CD14 and CD16 expression, but the correspondence is approximate rather than exact, and gene expression comparisons between mouse and human monocyte subsets reveal significant divergence alongside the expected similarities.
For researchers working on tumor immunology or infectious disease, this gap means that a mouse study showing a critical role for Gr-1+ cells in some process cannot be assumed to predict the same role for any particular human cell type. Human MDSCs are defined by a different and still-debated combination of surface markers, and the field has spent years trying to harmonize criteria across laboratories. The Gr-1 marker is deeply informative within the mouse system but represents a species-specific tool, not a universal immunological principle.
When Old Gr-1 Data Is Still Worth Reading
Thousands of published papers describe experiments performed with the RB6-8C5 antibody before the distinction between Ly6G and Ly6C was widely appreciated. These papers are not useless, but they require careful interpretation. If a study depleted “Gr-1+ cells” and saw a phenotype, the question is always whether the effect was driven by the loss of neutrophils, the loss of inflammatory monocytes, or both. In some infection models, re-analysis with Ly6G- and Ly6C-specific reagents has confirmed the original conclusions. In others, the picture changed substantially once the two cell populations could be separated.
For anyone reading older literature, a useful rule of thumb is to check whether the staining intensity was reported. Gr-1-bright cells are overwhelmingly neutrophils, because Ly6G produces a strong signal with RB6-8C5. Gr-1-dim or Gr-1-intermediate cells are more likely to be monocytes expressing only Ly6C. If the original paper gated broadly on all Gr-1+ events without distinguishing intensity, the conclusions about which cell type was responsible are inherently ambiguous. Many of the most influential early studies in MDSC biology fall into this category, which is one reason the field has had to revisit and refine so many of its foundational claims.